CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 217 filers reported holding CHEMOCENTRYX INC in Q3 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,473,000 | +91.2% | 86,576 | -8.3% | 0.06% | +100.0% |
| Q2 2022 | $2,340,000 | -31.2% | 94,450 | -30.4% | 0.03% | -16.7% |
| Q1 2022 | $3,402,000 | -34.0% | 135,698 | -4.2% | 0.04% | -30.8% |
| Q4 2021 | $5,156,000 | +152.5% | 141,600 | +18.6% | 0.05% | +160.0% |
| Q3 2021 | $2,042,000 | +201.2% | 119,400 | +135.8% | 0.02% | +185.7% |
| Q2 2021 | $678,000 | -74.9% | 50,636 | -4.1% | 0.01% | -75.0% |
| Q1 2021 | $2,706,000 | -21.6% | 52,813 | -5.2% | 0.03% | -28.2% |
| Q4 2020 | $3,451,000 | +38.2% | 55,730 | +22.3% | 0.04% | +18.2% |
| Q3 2020 | $2,497,000 | -18.7% | 45,558 | -14.6% | 0.03% | -23.3% |
| Q2 2020 | $3,070,000 | – | 53,351 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |